The Life Sciences Capital Forum convenes a curated group of executives responsible for capital execution across the life sciences industry.
Through moderated roundtable discussions and private leadership sessions, participants explore the real challenges shaping facility expansion, validation strategy, workforce readiness, and operational execution across modern pharmaceutical and biotech organizations.
The Life Sciences Capital Forum is an invite-only roundtable series designed for executives involved in the planning, delivery, and oversight of major life sciences capital initiatives.
Through moderated discussion and curated participation, the forum creates a trusted environment for leaders to exchange perspective on the challenges shaping pharmaceutical and biotech infrastructure today.
Rather than presentations or product promotion, each session focuses on peer-level dialogue around topics such as facility expansion, commissioning and validation strategy, workforce constraints, and operational readiness.
The goal is simple:
Create a space where experienced leaders can share lessons learned, surface emerging risks, and explore how the industry is adapting to an increasingly complex capital landscape.
Participants in the forum represent leaders responsible for delivering complex life sciences projects across engineering, operations, validation, and capital program leadership.
Each session is designed to foster meaningful discussion and relationship-building among professionals navigating similar challenges across the industry.
Engage in moderated discussions with industry peers responsible for major life sciences capital programs. Conversations focus on real-world challenges shaping facility expansion, validation execution, and operational readiness.
Gain insight into how other organizations are approaching workforce planning, validation strategy, compliance risk, and large-scale infrastructure delivery in a rapidly evolving regulatory and operational environment.
Build relationships with experienced leaders across pharmaceutical organizations, engineering firms, validation teams, and infrastructure partners involved in shaping the future of life sciences facilities.
The forum brings together a cross-section of leaders from across the life sciences ecosystem, creating a unique environment where operational leaders, engineering experts, and infrastructure partners can share perspective and collaborate around common challenges.
Participation typically includes leaders from:
Pharmaceutical and biotechnology organizations
Engineering and capital program leaders
CQV and validation specialists
Facility and operational readiness experts
Infrastructure and technology innovators
Opening Context
Each session begins with a brief framing of the topic and emerging industry dynamics influencing life sciences capital execution.
Opening Remarks
Leadership Roundtable
A moderated discussion among invited participants exploring real-world challenges and lessons learned from recent capital programs.
Moderated Discussion
Industry Perspectives
Participants exchange insights around workforce strategy, validation planning, infrastructure scaling, and operational readiness.
Open Dialogue
Relationship Building
Sessions conclude with informal discussion and follow-on connection opportunities among participants.
Networking & Follow-Up
The forum is designed for professionals responsible for planning, executing, or supporting capital initiatives across the life sciences sector.
Participants typically include leaders involved in:
Capital project execution and infrastructure strategy
Facility expansion and operational readiness
Commissioning, qualification, and validation programs
Engineering and technical operations leadership
Workforce planning for large-scale capital initiatives
Compliance and inspection readiness during expansion
The Life Sciences Capital Forum is designed to facilitate meaningful dialogue and relationship building among leaders navigating the same operational and strategic challenges.
Hear how other organizations are navigating workforce constraints, regulatory pressure, and large-scale facility expansion.
Gain practical insight into how experienced leaders are managing validation strategy, multi-vendor coordination, and capital execution risk.
Build trusted connections with peers across the life sciences ecosystem who are shaping major capital initiatives.
Conversations from each session inform future roundtables and industry discussions, creating a continuous exchange of insight across the community.
Participation in the forum is invite-only and designed to maintain a high-quality leadership discussion.
Leaders responsible for shaping or executing life sciences capital initiatives are encouraged to request participation in an upcoming session.
Selected participants will receive additional details about upcoming roundtables and the in-person gatherings.
Short request form to express interest
Participation is curated to ensure balanced discussion
Sessions held quarterly
VIP in-person gatherings
If you have questions that are not addressed here, include them in your application or contact our team directly.
Participants include executives and senior leaders from pharmaceutical companies, engineering firms, validation teams, and infrastructure partners involved in life sciences capital projects.
The forum is curated to ensure balanced discussion among leaders representing different perspectives across the life sciences capital ecosystem.
Sessions explore challenges shaping life sciences infrastructure today, including capital execution risk, workforce strategy, validation planning, regulatory readiness, and facility expansion.
